Skip to main content
PROTEOME SCIENCES PLC logo

PROTEOME SCIENCES PLC — Investor Relations & Filings

Ticker · PRM ISIN · GB0003104196 LEI · 213800Q62ICXANKU2986 IL Professional, scientific and technical activities
Open in API
Filings indexed 279 across all filing types
Latest filing 2026-02-04 Major Shareholding Noti…
Country GB United Kingdom
Listing IL PRM

About PROTEOME SCIENCES PLC

https://www.proteomics.com/

Proteome Sciences PLC is a specialized Contract Research Organization (CRO) focused on applied proteomics and peptidomics. The company provides comprehensive mass spectrometry-based analytical services to support drug discovery, development, and biomarker identification for precision medicine. Its services cover the full workflow from sample preparation and proteome characterization to bioinformatics data interpretation and reporting, handling diverse biological samples. A key offering is its proprietary TMT® and TMTpro® isobaric tags, which the company invented, developed, and exclusively manufactures for multiplexed protein quantification. These reagents are distributed globally to the mass spectrometry community. The company serves the biopharmaceutical sector, operating under ISO 9001:2015 and Good Clinical Laboratory Practice (GCLP) standards for its targeted assays.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings', which is a regulatory requirement for shareholders to disclose when their interest in a company crosses specific voting rights thresholds. This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2026-02-04 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings'. This is a regulatory requirement for shareholders to disclose when their interest in a company crosses certain thresholds. This aligns perfectly with the definition of a 'Major Shareholding Notification' (MRQ).
2026-02-03 English
Result of Oversubscribed Retail Offer
Share Issue/Capital Change Classification · 1% confidence The document is an official announcement from Proteome Sciences PLC regarding the successful completion and oversubscription of a 'Retail Offer' and the subsequent issuance of new shares. It details the number of shares issued, the issue price, the total proceeds raised, and the expected admission to trading on the London Stock Exchange (AIM). This falls squarely under the definition of a 'Share Issue/Capital Change' (SHA) as it pertains to the issuance of new equity and changes to the company's capital structure.
2026-01-28 English
Retail Offer to raise up to £60,000
Capital/Financing Update Classification · 1% confidence The document is an official announcement from Proteome Sciences PLC regarding a 'Retail Offer' to raise capital through the issuance of new ordinary shares. It details the offer price, the purpose of the funds, the expected timetable, and the eligibility criteria for investors. This falls under the category of capital raising and financing activities. It is not a report itself, but an announcement of a financial transaction, fitting the 'Capital/Financing Update' category.
2026-01-26 English
£840,000 Fundraise and Retail Offer
Capital/Financing Update Classification · 1% confidence The document is an official announcement from Proteome Sciences plc regarding a capital raise of £840,000 through the issuance of new ordinary shares. It details the placing, subscription by directors/major shareholders, use of proceeds, and related party transactions. While it contains a PDMR notification at the end, the primary purpose of the document is to announce a financing event (fundraise). Therefore, it is classified as a Capital/Financing Update.
2026-01-26 English
Two Further Substantial Contracts for PRM
Regulatory Filings Classification · 1% confidence The document is a regulatory news announcement (RNS) issued by Proteome Sciences plc regarding the securing of two new substantial contracts. It is not a financial report, presentation, or notice of publication, but rather a direct announcement of business activity (contract wins). As it does not fit into specific categories like M&A, dividends, or director dealings, it falls under the general regulatory filing category.
2026-01-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.